Dow, Aksa jointly manufacture carbon fibre derivatives

Dow, Aksa to jointly manufacture carbon fibre and derivatives

10:42 AM, 7th June 2011
Dow, Aksa to jointly manufacture carbon fibre and derivatives
Dow and Aksa sign MoU.

The companies will jointly look to offer carbon fibre and derivatives to growing energy, transportation and infrastructure markets.

 

MIDLAND, US/ISTANBUL, TURKEY: Dow Europe GmbH, a subsidiary of Dow Chemical Company and Aksa Akrilik Kimya Sanayii (Aksa), have signed a memorandum of understanding (MOU) to form a joint venture to manufacture and globally commercialize carbon fibre and derivatives.

 

The companies will explore opportunities to create fully-integrated production facilities for the manufacture and global supply of carbon fibre and derivatives. Further, they will examine opportunities to develop and market a broad range of products and technical service offerings in the carbon fibre-based composites industry.

 

“This new partnership with Aksa will advance Dow’s innovation agenda and broaden our down-stream, integrated solutions offering. Together, Aksa and Dow will look to deliver innovative solutions that address some of the world’s most pressing challenges such as increasing the energy capture of wind turbines, improving the fuel economy of automobiles and extending the life of roads and buildings,” said Andrew N Liveris, Chairman and CEO, Dow Chemical.

 

“By partnering with Dow, we will strengthen Aksa’s leadership position in both our local community and global markets. Aksa has been a pioneer at introducing new products and technologies and with this partnership will accelerate our pace in the future. This technology race to develop carbon fibre composites will offer improved products and solutions for the betterment of mankind,” said Mehmet Ali Berkman, Chairman of the Board, Aksa.

(C) WOC News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Scientists find new drug target in breast cancer

  Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new trea ...

Read more
Rhodia, Sibur form surfactants joint venture in Russia

  PARIS, FRANCE: Rhodia and Sibur will create a joint venture in specialty surfactants. It is expected, the new 50:50 joint venture will have a ...

Read more
BASF partners with research institutes to reduce crop loss in Africa

Four-year agreement to combat “invisible” Striga weed Partnership includes leading agricultural research institutes     ...

Read more
AkzoNobel, Quangxi CAVA to jointly build TiO2 plant in China

  AMSTERDAM, THE NETHERLANDS: AkzoNobel has partnered with Quangxi CAVA Titanium Industry Co Ltd in China, for the production and supply of tita ...

Read more
Prof Lauren Webb selected for ‘women in chemistry’ award

TEXAS, US: Professor Lauren Webb has been selected to receive the 2011 Iota Sigma Pi Agnes Fay Morgan Research Award. She is invited to the Iota Sigma ...

Read more
CAS registers 60 millionth substance

  Therapeutic substance originates from Chinese patent, signifying role of Pacific Rim research in the field of chemical and scientific publishi ...

Read more